Moderna’s new CFO took a cut in salary to jump to the mRNA revolutionary. But then there’s the rest of the compensation package

David Meline took a little off the top of his salary when he jumped from the CFO post at giant Amgen to become the numbers czar at the upstart vaccines revolutionary Moderna. But the SEC filing that goes with a major hire also illustrates how it puts him in line…

Click to view original post